216 related articles for article (PubMed ID: 18291370)
1. Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.
Zhang J; Groff RF; Chen XH; Browne KD; Huang J; Schwartz ED; Meaney DF; Johnson VE; Stein SC; Rojkjaer R; Smith DH
Exp Neurol; 2008 Apr; 210(2):645-55. PubMed ID: 18291370
[TBL] [Abstract][Full Text] [Related]
2. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
Sapsford W; Watts S; Cooper G; Kirkman E
J Trauma; 2007 Apr; 62(4):868-79. PubMed ID: 17426541
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
5. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
Zaaroor M; Soustiel JF; Brenner B; Bar-Lavie Y; Martinowitz U; Levi L
Acta Neurochir (Wien); 2008 Jul; 150(7):663-8. PubMed ID: 18473114
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Dickneite G; Dörr B; Kaspereit F; Tanaka KA
J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic therapy for the treatment of intracranial hemorrhage.
Liu-DeRyke X; Rhoney D
Pharmacotherapy; 2008 Apr; 28(4):485-95. PubMed ID: 18363532
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Martinowitz U; Michaelson M;
J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
White CE; Schrank AE; Baskin TW; Holcomb JB
Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
[TBL] [Abstract][Full Text] [Related]
10. [The use of recombinant activated factor VII in traumatic intracranial haemorrhage].
Novak V; Mitov L; Rancić Z; Petrović B; Novak M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():193-8. PubMed ID: 19562867
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries.
Klemcke HG; Delgado A; Holcomb JB; Ryan KL; Burke A; DeGuzman R; Scherer M; Cortez D; Uscilowicz J; Macaitis JM; Bliss J; Wojtaszczyk J; Christensen S; Currier H; Pusateri AE
J Trauma; 2005 Jul; 59(1):155-61; discussion 161. PubMed ID: 16096556
[TBL] [Abstract][Full Text] [Related]
13. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Stein DM; Dutton RP; Kramer ME; Scalea TM
J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant factor VIIa to facilitate organ donation in trauma patients with devastating neurologic injury.
Stein DM; Dutton RP; Alexander C; Miller J; Scalea TM
J Am Coll Surg; 2009 Jan; 208(1):120-5. PubMed ID: 19228513
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII for acute intracerebral hemorrhage.
Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
[TBL] [Abstract][Full Text] [Related]
17. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
18. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic drugs for traumatic brain injury.
Perel P; Roberts I; Shakur H; Thinkhamrop B; Phuenpathom N; Yutthakasemsunt S
Cochrane Database Syst Rev; 2010 Jan; (1):CD007877. PubMed ID: 20091656
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
